Branham Law Group, LLP announces its investigation of Chemed Corporation ( NYSE: CHE ). This investigation focuses on whether company executives and administrators breached their fiduciary obligations by failing to disclose that Chemed engaged in a scheme to fraudulently bill Medicare for hospice services and failed to maintain adequate controls in its hospice enrollments and Medicare billings. It has been reported that a whistleblower complaint has also been filed alleging similar misconduct.
Concerned shareholders -- or anyone with additional information about this case -- who would like more information about their rights and potential remedies can contact attorney Trey Branham at (855) 722-5910 or firstname.lastname@example.org .
The allegations against Chemed include fraudulent Medicare billings for unqualified hospice care, profiting from unqualified hospice enrollments, and engaging in a premeditated plan to enroll unqualified hospice patients and fraudulently bill Medicare. Moreover, it appears that these actions were a result of Chemed’s failure to put in place proper internal controls. Finally, as a result of these actions, it appears that Chemed’s financial statements were significantly, and materially, overstated without a reasonable basis.
“These allegations of fraudulent activity and overstated financials have given rise to great concern about damage to the company and its shareholders,” said attorney Trey Branham.The Branham Law Group, LLP has extensive experience in securities and commercial litigation and handled claims of investor fraud, partnership oppression, shareholder derivative suits, and class actions of all types. The Branham Law Group also advises whistleblowers on appropriate courses of action.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV